Payment overview · 2025
General Payments
$180.71
9 reported records · 7 companies
Healthcare provider profile · identity verified
John Edward Pierce, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · PERRYSBURG, OH · NPI 1598755712
Verified facts
What the public records show
CMS Open Payments records show John Edward Pierce, M.D. received $180.71 in general payments during 2025 across 9 reported records.
Dexcom, Inc. accounted for 27.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 7 associated products.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 393 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 21 claims for Paxlovid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $49.21 | 27.2% | 2 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $37.95 | 21.0% | 2 | 2025 |
| Inspire Medical Systems, Inc. | Unresolved — no canonical attribution shown | $22.74 | 12.6% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $19.30 | 10.7% | 1 | 2025 |
| SI-BONE, INC. | Unresolved — no canonical attribution shown | $18.49 | 10.2% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $17.94 | 9.9% | 1 | 2025 |
| Bayer Healthcare Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $15.08 | 8.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $180.71 | 9 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $49.21 | 2 | 2025 |
Source payment records
|
|||||
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $37.95 | 2 | 2025 |
Source payment records
|
|||||
| INSPIRE Normalized: inspire |
Device | Inspire Medical Systems, Inc. | $22.74 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $19.30 | 1 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $17.94 | 1 | 2025 |
Source payment records
|
|||||
| ZAVZPRET Normalized: zavzpret |
Drug | PFIZER INC. | $17.94 | 1 | 2025 |
Source payment records
|
|||||
| Kerendia Normalized: kerendia |
Drug | Bayer Healthcare Pharmaceuticals Inc. | $15.08 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
393 | 77 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | PAXLOVID open payments reported associated product |
CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432 |
Paxlovid · 2024 Exact normalized brand match · 1 Part D row |
21 | 21 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1530 | 371 |
| Levothyroxine Sodium | Levothyroxine Sodium | 827 | 179 |
| Furosemide | Furosemide | 772 | 191 |
| Amlodipine Besylate | Amlodipine Besylate | 722 | 165 |
| Losartan Potassium | Losartan Potassium | 645 | 152 |
| Potassium Chloride | Potassium Chloride | 584 | 125 |
| Gabapentin | Gabapentin | 577 | 130 |
| Metoprolol Tartrate | Metoprolol Tartrate | 566 | 133 |
| Pantoprazole Sodium | Pantoprazole Sodium | 543 | 135 |
| Lisinopril | Lisinopril | 515 | 134 |
| Metoprolol Succinate | Metoprolol Succinate | 490 | 116 |
| Omeprazole | Omeprazole | 471 | 128 |
| Eliquis | Apixaban | 393 | 77 |
| Sertraline Hcl | Sertraline Hcl | 392 | 75 |
| Tamsulosin Hcl | Tamsulosin Hcl | 367 | 100 |
| Carvedilol | Carvedilol | 358 | 89 |
| Trazodone Hcl | Trazodone Hcl | 352 | 87 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 332 | 69 |
| Metformin Hcl | Metformin Hcl | 322 | 98 |
| Simvastatin | Simvastatin | 315 | 93 |
| Citalopram Hbr | Citalopram Hydrobromide | 305 | 79 |
| Allopurinol | Allopurinol | 281 | 70 |
| Clopidogrel | Clopidogrel Bisulfate | 274 | 62 |
| Famotidine | Famotidine | 271 | 70 |
| Duloxetine Hcl | Duloxetine Hcl | 258 | 55 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 229 | 75 |
| Alprazolam | Alprazolam | 229 | 55 |
| Hydrochlorothiazide | Hydrochlorothiazide | 229 | 68 |
| Buspirone Hcl | Buspirone Hcl | 217 | 41 |
| Tramadol Hcl | Tramadol Hcl | 204 | 56 |
| Escitalopram Oxalate | Escitalopram Oxalate | 200 | 43 |
| Ozempic | Semaglutide | 198 | 35 |
| Jardiance | Empagliflozin | 191 | 54 |
| Spironolactone | Spironolactone | 191 | 50 |
| Trulicity | Dulaglutide | 173 | 22 |
| Donepezil Hcl | Donepezil Hcl | 168 | 37 |
| Tizanidine Hcl | Tizanidine Hcl | 168 | 45 |
| Memantine Hcl | Memantine Hcl | 166 | 37 |
| Lorazepam | Lorazepam | 158 | 37 |
| Fluticasone Propionate | Fluticasone Propionate | 155 | 60 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 153 | 41 |
| Metformin Hcl Er | Metformin Hcl | 152 | 43 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 151 | 37 |
| Mirtazapine | Mirtazapine | 148 | 44 |
| Hydralazine Hcl | Hydralazine Hcl | 147 | 43 |
| Meloxicam | Meloxicam | 146 | 47 |
| Prednisone | Prednisone | 145 | 99 |
| Pioglitazone Hcl | Pioglitazone Hcl | 142 | 40 |
| Benazepril Hcl | Benazepril Hcl | 141 | 36 |
| Levetiracetam | Levetiracetam | 141 | 17 |
| Pravastatin Sodium | Pravastatin Sodium | 141 | 35 |
| Montelukast Sodium | Montelukast Sodium | 140 | 29 |
| Glimepiride | Glimepiride | 139 | 37 |
| Risperidone | Risperidone | 136 | 13 |
| Fluoxetine Hcl | Fluoxetine Hcl | 129 | 29 |
| Farxiga | Dapagliflozin Propanediol | 127 | 32 |
| Clonidine Hcl | Clonidine Hcl | 126 | 27 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 122 | 31 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 121 | 33 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 121 | 45 |
| Januvia | Sitagliptin Phosphate | 118 | 26 |
| Ibuprofen | Ibuprofen | 117 | 42 |
| Amitriptyline Hcl | Amitriptyline Hcl | 115 | 29 |
| Azithromycin | Azithromycin | 115 | 91 |
| Divalproex Sodium | Divalproex Sodium | 111 | 19 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 111 | 29 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 110 | 30 |
| Telmisartan | Telmisartan | 110 | 34 |
| Alendronate Sodium | Alendronate Sodium | 107 | 27 |
| Bumetanide | Bumetanide | 107 | 24 |
| Pregabalin | Pregabalin | 106 | 28 |
| Tresiba Flextouch U-200 | Insulin Degludec | 106 | 25 |
| Doxycycline Hyclate | Doxycycline Hyclate | 105 | 64 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 104 | 26 |
| Entresto | Sacubitril/Valsartan | 103 | suppressed |
| Aripiprazole | Aripiprazole | 100 | 16 |
| Bupropion Xl | Bupropion Hcl | 99 | 26 |
| Xarelto | Rivaroxaban | 99 | 24 |
| Clonazepam | Clonazepam | 94 | 22 |
| Diazepam | Diazepam | 93 | 23 |
| Midodrine Hcl | Midodrine Hcl | 93 | 27 |
| Finasteride | Finasteride | 92 | 27 |
| Cephalexin | Cephalexin | 91 | 60 |
| Warfarin Sodium | Warfarin Sodium | 90 | 21 |
| Nystatin | Nystatin | 86 | 47 |
| Zolpidem Tartrate | Zolpidem Tartrate | 83 | 16 |
| Ezetimibe | Ezetimibe | 79 | 18 |
| Ondansetron Hcl | Ondansetron Hcl | 79 | 51 |
| Paroxetine Hcl | Paroxetine Hcl | 77 | 11 |
| Topiramate | Topiramate | 73 | 13 |
| Vraylar | Cariprazine Hcl | 71 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 70 | 16 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 70 | 17 |
| Diltiazem Hcl | Diltiazem Hcl | 69 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 68 | 14 |
| Atenolol | Atenolol | 66 | 24 |
| Quetiapine Fumarate | Quetiapine Fumarate | 65 | 19 |
| Oxybutynin Chloride | Oxybutynin Chloride | 63 | 12 |
| Meclizine Hcl | Meclizine Hcl | 62 | 23 |
| Synthroid | Levothyroxine Sodium | 62 | 21 |
| Fenofibrate | Fenofibrate | 61 | 15 |
| Humalog Kwikpen U-100 | Insulin Lispro | 60 | 20 |
| Nifedipine Er | Nifedipine | 60 | 21 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 59 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 59 | 13 |
| Etodolac | Etodolac | 57 | 16 |
| Lamotrigine | Lamotrigine | 56 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 55 | suppressed |
| Novolog Flexpen | Insulin Aspart | 55 | 17 |
| Amoxicillin | Amoxicillin | 54 | 43 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 54 | 37 |
| Breo Ellipta | Fluticasone/Vilanterol | 53 | 13 |
| Digoxin | Digoxin | 53 | 11 |
| Olanzapine | Olanzapine | 53 | 12 |
| Celecoxib | Celecoxib | 52 | 13 |
| Symbicort | Budesonide/Formoterol Fumarate | 52 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 51 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 50 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 49 | 12 |
| Latanoprost | Latanoprost | 48 | 12 |
| Metolazone | Metolazone | 48 | 16 |
| Valacyclovir | Valacyclovir Hcl | 48 | 20 |
| Fluconazole | Fluconazole | 47 | 34 |
| Memantine Hcl Er | Memantine Hcl | 47 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 46 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 46 | 33 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 45 | 17 |
| Primidone | Primidone | 45 | 14 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 44 | 30 |
| Rexulti | Brexpiprazole | 44 | suppressed |
| Carbamazepine | Carbamazepine | 43 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 43 | 13 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 42 | suppressed |
| Mresvia | Rsv Vaccine, Pref, Mrna/Pf | 42 | 41 |
| Glipizide | Glipizide | 41 | 11 |
| Torsemide | Torsemide | 41 | suppressed |
| Baclofen | Baclofen | 39 | 13 |
| Levofloxacin | Levofloxacin | 39 | 33 |
| Glipizide Er | Glipizide | 38 | suppressed |
| Klor-Con M20 | Potassium Chloride | 37 | 16 |
| Lovastatin | Lovastatin | 37 | suppressed |
| Myrbetriq | Mirabegron | 37 | 13 |
| Tradjenta | Linagliptin | 37 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 36 | 11 |
| Fluocinonide | Fluocinonide | 36 | 30 |
| Nitroglycerin | Nitroglycerin | 36 | 22 |
| Ventolin Hfa | Albuterol Sulfate | 35 | 12 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 34 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 34 | 11 |
| Hydrocortisone | Hydrocortisone | 34 | 13 |
| Jantoven | Warfarin Sodium | 34 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 34 | 28 |
| Brilinta | Ticagrelor | 33 | suppressed |
| Estradiol | Estradiol | 33 | 15 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 31 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 31 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 30 | suppressed |
| Loperamide | Loperamide Hcl | 30 | 21 |
| Terazosin Hcl | Terazosin Hcl | 30 | suppressed |
| Cilostazol | Cilostazol | 29 | suppressed |
| Colchicine | Colchicine | 29 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 29 | 12 |
| Invokana | Canagliflozin | 29 | suppressed |
| Levemir Flexpen | Insulin Detemir | 29 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 29 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 29 | 22 |
| Nabumetone | Nabumetone | 28 | suppressed |
| Naproxen | Naproxen | 28 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 28 | suppressed |
| Mupirocin | Mupirocin | 27 | 15 |
| Niacin Er | Niacin | 26 | suppressed |
| Nystop | Nystatin | 26 | 18 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 25 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 24 | suppressed |
| Rivastigmine | Rivastigmine | 24 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 24 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 23 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 23 | 23 |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 23 | suppressed |
| Gemtesa | Vibegron | 23 | suppressed |
| Lidocaine | Lidocaine | 23 | 12 |
| Novolin N Flexpen | Insulin Nph Human Isophane | 23 | suppressed |
| Praluent Pen | Alirocumab | 23 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 22 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 22 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 22 | suppressed |
| Linzess | Linaclotide | 22 | suppressed |
| Meropenem | Meropenem | 22 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 22 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 22 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 22 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 21 | 13 |
| Constulose | Lactulose | 21 | suppressed |
| Cyclosporine | Cyclosporine | 21 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 21 | 21 |
| Promethazine Hcl | Promethazine Hcl | 21 | suppressed |
| Ciclopirox | Ciclopirox Olamine | 20 | suppressed |
| Lansoprazole | Lansoprazole | 20 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 20 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 20 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 19 | suppressed |
| Daptomycin | Daptomycin | 19 | suppressed |
| Nyamyc | Nystatin | 19 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 19 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 18 | suppressed |
| Klor-Con M10 | Potassium Chloride | 18 | suppressed |
| Qulipta | Atogepant | 18 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 17 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 17 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 17 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 17 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 17 | suppressed |
| Lactulose | Lactulose | 17 | suppressed |
| Metronidazole | Metronidazole | 17 | 13 |
| Mirabegron Er | Mirabegron | 17 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 17 | suppressed |
| Mounjaro | Tirzepatide | 17 | suppressed |
| Sulfasalazine | Sulfasalazine | 17 | suppressed |
| Trospium Chloride | Trospium Chloride | 17 | suppressed |
| Valsartan | Valsartan | 17 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 16 | 13 |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 16 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 16 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 16 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 16 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 16 | suppressed |
| Sotalol | Sotalol Hcl | 16 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 16 | suppressed |
| Anastrozole | Anastrozole | 15 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 15 | suppressed |
| Calcitriol | Calcitriol | 15 | suppressed |
| Chlorthalidone | Chlorthalidone | 15 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 15 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 15 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 15 | suppressed |
| Movantik | Naloxegol Oxalate | 15 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 15 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Verapamil Er | Verapamil Hcl | 15 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 14 | suppressed |
| Creon | Lipase/Protease/Amylase | 14 | suppressed |
| Elinest | Norgestrel-Ethinyl Estradiol | 14 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 14 | suppressed |
| Guanfacine Hcl | Guanfacine Hcl | 14 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 14 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 14 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Alprazolam Er | Alprazolam | 13 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 13 | 12 |
| Belbuca | Buprenorphine Hcl | 13 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 13 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 13 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 13 | suppressed |
| Febuxostat | Febuxostat | 13 | suppressed |
| Gemfibrozil | Gemfibrozil | 13 | suppressed |
| Humira | Adalimumab | 13 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 13 | suppressed |
| Insulin Lispro | Insulin Lispro | 13 | suppressed |
| Ketoconazole | Ketoconazole | 13 | suppressed |
| Nexium | Esomeprazole Magnesium | 13 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 13 | suppressed |
| Ranolazine Er | Ranolazine | 13 | suppressed |
| Roflumilast | Roflumilast | 13 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 12 | suppressed |
| Dulera | Mometasone/Formoterol | 12 | suppressed |
| Eszopiclone | Eszopiclone | 12 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 12 | suppressed |
| Methotrexate | Methotrexate Sodium | 12 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 12 | suppressed |
| Sucralfate | Sucralfate | 12 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 12 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Clonidine | Clonidine | 11 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 11 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 11 | suppressed |
| Entacapone | Entacapone | 11 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 11 | suppressed |
| Ibu | Ibuprofen | 11 | suppressed |
| Klayesta | Nystatin | 11 | suppressed |
| Ondansetron Odt | Ondansetron | 11 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 11 | suppressed |
| Premarin | Estrogens, Conjugated | 11 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 11 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $180.71 · 9 records | Dexcom, Inc. | Cologuard Collection Kit, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, INSPIRE, Kerendia, NURTEC ODT, ZAVZPRET | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with PFIZER INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error